A consortium of scientists, co-led by Mass General’s Bruce Walker, MD, is working to uncover the biological secrets of the coronavirus.
The unrestricted funding of the MGH Research Scholars program empowers scientists to meet the challenges of the COVID-19 pandemic.
Mass General clinicians who treat substance use disorders are putting new regulatory changes into action for their patients during the pandemic.
Addressing one of the greatest challenges of modern cancer treatment, Russell Jenkins, MD, PhD, is working to predict who will respond to immunotherapy treatment.
Using single-celled yeast, a trailblazing researcher at the Mass General Cancer Center has developed a way to lure dormant cancer cells out of hiding so cancer therapy can do its work.
Lily Haseotes Bentas and her husband, Efthemios J. Bentas, are creating a lasting endowment for cancer research with a focus on women scientists.
In labs across Mass General, researchers are guiding patient blood samples through the tiny channels of an innovative device that could open doors to faster, easier cancer detection.
Raina McMahan leads a team of Mass General recovery coaches who tap their personal experience with substance use disorder to guide others toward recovery.
Physicians and researchers at the Mass General Cancer Center are using innovative therapies and new approaches to extend the lives of patients with cancer that has spread to the brain.
Landing a one-two punch with immunotherapy, researchers treat the deadly brain cancer, glioblastoma, in the laboratory to pave the way for human trials.